TuHURA Biosciences, Inc./NV (HURA) stock
HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.36−0.01 (-0.73%)
Close on Nov 19, 2026Market cap $86.67MP/E –Yield –
TuHURA Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
TuHURA Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$29.69M. For fiscal 2025 it was -$27.63M. The highest annual figure on record is -$228.69K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.63M | – |
| FY2023 | Jun 30, 2023 | -$11.87M | – |
| FY2022 | Jun 30, 2022 | -$20.39M | – |
| FY2021 | Jun 30, 2021 | -$18.86M | – |
| FY2020 | Jun 30, 2020 | -$7.93M | – |
| FY2019 | Jun 30, 2019 | -$6.33M | – |
| FY2018 | Jun 30, 2018 | -$9.85M | – |
| FY2017 | Jun 30, 2017 | -$8.02M | – |
| FY2016 | Jun 30, 2016 | -$5.15M | – |
| FY2013 | Dec 31, 2013 | -$5.52M | – |
| FY2012 | Dec 31, 2012 | -$578.04K | – |
| FY2011 | Dec 31, 2011 | -$228.69K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$8.63M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$4.41M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$5.56M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$11.09M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$6.25M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$4.74M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$1.51M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$1.83M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$2.16M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$6.37M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$4.99M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$5.22M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$5.10M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$5.07M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$4.69M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$4.63M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$5.43M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$4.11M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$2.58M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$1.37M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$1.71M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$2.27M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$1.81M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$1.46M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$964.95K | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$2.08M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$2.53M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$2.81M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$2.13M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$2.37M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$3.45M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$1.51M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$1.45M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$1.61M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$1.55M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$956.92K | – |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -$1.23M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -$1.40M | – |
| Q4 FY2013CQ4 2013 | Dec 31, 2013 | -$1.03M | – |
| Q3 FY2013CQ3 2013 | Sep 30, 2013 | -$1.11M | – |
See a number that looks wrong?